Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA approves Novo Nordisk's Tretten to treat rare genetic clotting disorder
Yahoo/Fly on the Wall
Monday, December 23, 2013 - 3:22pm
tags:
Novo Nordisk, Tretten, FDA, congenital Factor XIII A-subunit deficiency
Update on Endo's Acquisition Strategy
Yahoo/Zacks.com
Monday, December 23, 2013 - 12:05pm
tags:
M&A, Endo Health Solutions
United Therapeutics Shares Gain on FDA Hypertension Approval
Bloomberg
Monday, December 23, 2013 - 11:27am
tags:
FDA, United Therapeutics, PAH, pulmonary arterial hypertension
The Affordable Care Act Gives Drugmakers A Boost: CMS
Pharmalot
Monday, December 23, 2013 - 11:24am
tags:
Affordable Care Act
Bristol-Myers sale of diabetes franchise positive, says BMO Capital
The Fly on the Wall
Monday, December 23, 2013 - 11:12am
tags:
diabetes, M&A, Bristol-Myers Squibb, AstraZeneca
The Avorn-Stossel Debate On GSK Halting Payment To Doctors For Drug Promotion
Forbes
Monday, December 23, 2013 - 11:02am
tags:
GSK, physician payments
Elliott denies it may accept McKesson's Celesio bid
Reuters
Monday, December 23, 2013 - 11:01am
tags:
Celesio, McKesson, M&A
Tesaro nausea drug effective in late-stage trials
Reuters
Monday, December 23, 2013 - 11:00am
tags:
Tesaro, rolapitant, chemotherapy-induced nausea and vomiting
Will FDA Widen Use For The Vasecpa Fish Oil Pill, After All?
Pharmalot
Monday, December 23, 2013 - 10:26am
tags:
FDA, Vascepa, Amarin
Diabetes Programs Now Crucial For Eli Lilly
Seeking Alpha
Monday, December 23, 2013 - 10:24am
tags:
diabetes, Eli Lilly, Novo Nordisk, Teva, Cymbalta, generics
Did One Of The Top 10 Upside Surprises In The History Of The Biotech Sector Just Happen?
Forbes
Monday, December 23, 2013 - 10:22am
tags:
Remodulin, PAH, pulmonary arterial hypertension, Orenitram, United Therapeutics
Neostem Stands To Benefit From Stem-Cell Deals
Seeking Alpha
Monday, December 23, 2013 - 10:05am
tags:
NeoStem, stem cells, Celgene, OncoMed
Why Is Novavax Breaking Out?
Motley Fool
Monday, December 23, 2013 - 10:04am
tags:
Novavax, vaccines
Ariad Pharmaceuticals Catches Fire
TheStreet.com
Monday, December 23, 2013 - 10:03am
tags:
Ariad Pharmaceuticals, Iclusig, FDA
Biogen's Biosimilars Vs. Amgen, Johnson & Johnson
Seeking Alpha
Monday, December 23, 2013 - 10:01am
tags:
Amgen, Biogen Idec, biosimilars, JNJ, Samsung Bioepis, Celltrion, Hospira, Remsima, Inflectra
Rexahn: A Turn Around Story For 2014
Seeking Alpha
Monday, December 23, 2013 - 9:59am
tags:
Rexahn, oncology
China Biotech Week In Review: Simcere Pharma Going Private
Seeking Alpha
Sunday, December 22, 2013 - 12:35pm
tags:
China, Chengdu Kanghong Pharmaceutical Group, MicuRx Pharmaceuticals, Alvogen, Lotus, Chi-Med, Sinopharm, Simcere, GSK, Shanghai Pharmaceutical
No News Is Good News for Amarin
Motley Fool
Sunday, December 22, 2013 - 12:32pm
tags:
Amarin
This Week in Biotech
Motley Fool
Sunday, December 22, 2013 - 12:28pm
tags:
GSK, Theravance, Ariad Pharmaceuticals, Gilead Sciences, AbbVie, Cubist Pharmaceuticals, Jazz Pharmaceuticals, Gentium
Merck's Pursuit Of Weight-Loss Business Is Savvy, Not Stupid
Forbes
Saturday, December 21, 2013 - 11:49am
tags:
Merck, weight loss, obesity

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.